FDA Clears First of Its Kind Suture Made Using DNA Technology
U.S. Department of Commerce’s ATP awards Tepha $2 million for development of cardiovascular tissue engineered products.
Tepha Announces First Human Usage of Medical Devices Derived from New Class of Resorbable Polymers
Tepha, Inc. Receives FDA Clearance for First Medical Device Derived from New Class of Biopolymers